Preparation of the new peptide drug ACTY116‐loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice.

MLA

Liu, Qiao, et al. “Preparation of the New Peptide Drug ACTY116‐loaded in Situ Forming Implants and Evaluation of Its Efficacy in Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy Induced by SU5416/Hypoxia in Mice.” Basic & Clinical Pharmacology & Toxicology, vol. 135, no. 1, July 2024, pp. 60–70. EBSCOhost, https://doi.org/10.1111/bcpt.14020.

APA

Liu, Q., Luo, Q., Zhong, B., Xiong, Y., Chen, X., & Li, X. (2024). Preparation of the new peptide drug ACTY116‐loaded in situ forming implants and evaluation of its efficacy in pulmonary arterial hypertension and right ventricular hypertrophy induced by SU5416/hypoxia in mice. Basic & Clinical Pharmacology & Toxicology, 135(1), 60–70. https://doi.org/10.1111/bcpt.14020

Chicago

Liu, Qiao, Qingman Luo, Bin Zhong, Yingxin Xiong, Xueling Chen, and Xiaohui Li. 2024. “Preparation of the New Peptide Drug ACTY116‐loaded in Situ Forming Implants and Evaluation of Its Efficacy in Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy Induced by SU5416/Hypoxia in Mice.” Basic & Clinical Pharmacology & Toxicology 135 (1): 60–70. doi:10.1111/bcpt.14020.